Safety of guselkumab in patients with psoriasis with a history of malignancy: 5-year results from the VOYAGE 1 and VOYAGE 2 trials

Andrew Blauvelt; Diamant Thaçi; Kim A. Papp; Vincent Ho; Kamran Ghoreschi; Byung Soo Kim; Megan Miller; Yaung Kaung Shen; Yin You; Daphne Chan; Jenny Yu; Ya Wen Yang; Mark G. Lebwohl; Alice B. Gottlieb; Jeffrey Crowley; Peter Foley

doi:10.1093/bjd/ljad081

Safety of guselkumab in patients with psoriasis with a history of malignancy: 5-year results from the VOYAGE 1 and VOYAGE 2 trials

Andrew Blauvelt^*, Diamant Thaçi, Kim A. Papp, Vincent Ho, Kamran Ghoreschi, Byung Soo Kim, Megan Miller, Yaung Kaung Shen, Yin You, Daphne Chan, Jenny Yu, Ya Wen Yang, Mark G. Lebwohl, Alice B. Gottlieb, Jeffrey Crowley, Peter Foley

^*Corresponding author for this work

Institute of Inflammation Medicine

4 Citations (Scopus)

Original language	English
Journal	British Journal of Dermatology
Volume	189
Issue number	1
Pages (from-to)	132-134
Number of pages	3
ISSN	0007-0963
DOIs	https://doi.org/10.1093/bjd/ljad081
Publication status	Published - 07.2023

Research Areas and Centers

Academic Focus: Center for Infection and Inflammation Research (ZIEL)
Centers: Center for Research on Inflammation of the Skin (CRIS)

DFG Research Classification Scheme

2.22-19 Dermatology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1093/bjd/ljad081

Cite this

Blauvelt, A., Thaçi, D., Papp, K. A., Ho, V., Ghoreschi, K., Kim, B. S., Miller, M., Shen, Y. K., You, Y., Chan, D., Yu, J., Yang, Y. W., Lebwohl, M. G., Gottlieb, A. B., Crowley, J., & Foley, P. (2023). Safety of guselkumab in patients with psoriasis with a history of malignancy: 5-year results from the VOYAGE 1 and VOYAGE 2 trials. British Journal of Dermatology, 189(1), 132-134. https://doi.org/10.1093/bjd/ljad081

@article{121a793c2e744851b3b829225cbc9153,

title = "Safety of guselkumab in patients with psoriasis with a history of malignancy: 5-year results from the VOYAGE 1 and VOYAGE 2 trials",

author = "Andrew Blauvelt and Diamant Tha{\c c}i and Papp, {Kim A.} and Vincent Ho and Kamran Ghoreschi and Kim, {Byung Soo} and Megan Miller and Shen, {Yaung Kaung} and Yin You and Daphne Chan and Jenny Yu and Yang, {Ya Wen} and Lebwohl, {Mark G.} and Gottlieb, {Alice B.} and Jeffrey Crowley and Peter Foley",

note = "Funding Information: This study was supported by Janssen Research & Development, LLC, Spring House, PA, USA.",

year = "2023",

month = jul,

doi = "10.1093/bjd/ljad081",

language = "English",

volume = "189",

pages = "132--134",

journal = "British Journal of Dermatology",

issn = "0007-0963",

number = "1",

}

Blauvelt, A, Thaçi, D, Papp, KA, Ho, V, Ghoreschi, K, Kim, BS, Miller, M, Shen, YK, You, Y, Chan, D, Yu, J, Yang, YW, Lebwohl, MG, Gottlieb, AB, Crowley, J & Foley, P 2023, 'Safety of guselkumab in patients with psoriasis with a history of malignancy: 5-year results from the VOYAGE 1 and VOYAGE 2 trials', British Journal of Dermatology, vol. 189, no. 1, pp. 132-134. https://doi.org/10.1093/bjd/ljad081

TY - JOUR

T1 - Safety of guselkumab in patients with psoriasis with a history of malignancy

T2 - 5-year results from the VOYAGE 1 and VOYAGE 2 trials

AU - Blauvelt, Andrew

AU - Thaçi, Diamant

AU - Papp, Kim A.

AU - Ho, Vincent

AU - Ghoreschi, Kamran

AU - Kim, Byung Soo

AU - Miller, Megan

AU - Shen, Yaung Kaung

AU - You, Yin

AU - Chan, Daphne

AU - Yu, Jenny

AU - Yang, Ya Wen

AU - Lebwohl, Mark G.

AU - Gottlieb, Alice B.

AU - Crowley, Jeffrey

AU - Foley, Peter

N1 - Funding Information: This study was supported by Janssen Research & Development, LLC, Spring House, PA, USA.

PY - 2023/7

Y1 - 2023/7

UR - http://www.scopus.com/inward/record.url?scp=85153931247&partnerID=8YFLogxK

U2 - 10.1093/bjd/ljad081

DO - 10.1093/bjd/ljad081

M3 - Letters

C2 - 36944555

AN - SCOPUS:85153931247

SN - 0007-0963

VL - 189

SP - 132

EP - 134

JO - British Journal of Dermatology

JF - British Journal of Dermatology

IS - 1

ER -

Safety of guselkumab in patients with psoriasis with a history of malignancy: 5-year results from the VOYAGE 1 and VOYAGE 2 trials

Research Areas and Centers

DFG Research Classification Scheme

UN SDGs

Access to Document

Other files and links

Cite this